KRYS vs QQQ Stock Comparison
KRYS currently leads QQQ in this stock comparison, with AIQ scores of 69 vs 46. The clearest difference is value, while QQQ has the stronger quality profile.
What is the main difference between KRYS and QQQ?
KRYS leads the current stock comparison as Krystal Biotech, Inc., with the clearest separation coming from value and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Krystal Biotech, Inc. vs Invesco QQQ Trust, Series 1
KRYS leads
KRYS leads by 23 AIQ points, primarily on Value and Risk Resilience, and the lead has widened from 10 points over 30 sessions.
Stable: 3 of 4 evidence groups support KRYS, its lead is widening, and its signal state is cleanly positive.
Krystal Biotech, Inc.
Invesco QQQ Trust, Series 1
The Algovestiq AIQ Score currently favors KRYS over QQQ, 69 versus 46 as of Nov 15, 2026. KRYS's advantage is driven primarily by stronger value and risk resilience, while QQQ holds the stronger quality profile. KRYS also shows the weaker technical structure relative to its 50-day moving average. 3 of 4 covered evidence groups favor KRYS today, and the comparison is rated Stable on stability. KRYS lead: Strengthening — the AIQ differential moved from 10 to 23 points over 30 sessions.
Compare Krystal Biotech, Inc. and Invesco QQQ Trust, Series 1 across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare KRYS and QQQ against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Value67 vs 13KRYS +54
- Risk Resilience69 vs 31KRYS +38
- Momentum58 vs 33KRYS +25
- Quality83 vs 93QQQ +10
3 of 4 evidence groups favor KRYS. KRYS’s edge is concentrated in value and risk resilience; QQQ keeps a meaningful quality edge.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Momentum -1, not enough on its own to move the overall score.
New signals
- MACD Bullish Crossover — bullish, momentum, short horizon
- MACD Histogram Expanding Bullish — bullish, momentum, short horizon
Largest factor move: Value +1
New signals
- Price Lost 200-Day MA — bearish, trend, long horizon
- Drawdown Recovery Signal — bullish, risk_regime, long horizon (-14.8%)
KRYS's lead widened by 1 AIQ point in the latest session.
Deeper signal detail for each name lives on its own signals page — KRYS and QQQ both carry a full feed there.
The central trade-off
KRYS (Krystal Biotech, Inc.): the stronger current systematic profile, led by value and risk resilience.
QQQ (Invesco QQQ Trust, Series 1): the counter-case, on quality, technicals.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
KRYSKRYS on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
EvenGrowth figures are not covered for both names.
Value
KRYSKRYS on the peer-relative Value factor, by 54 points.
Momentum
KRYSKRYS on the Momentum factor, by 25 points.
Lower downside
KRYSKRYS on Risk Resilience, by 38 points.
Analyst upside
EvenAnalyst targets are level or not covered for both names.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | KRYS | QQQ | Note |
|---|---|---|---|
| Implied upside to target | +40.4% | — | Level |
| Target dispersion | +5.8% | — | Lower is tighter analyst agreement |
| Consensus | Buy | — | Context, not a primary driver |
| Analysts covering | 12 | — | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
3 of 4 covered evidence groups favor KRYS. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | KRYS | 69 vs 46 |
| Fundamentals | Not covered | Not covered |
| Valuation | KRYS | Value 67 vs 13 |
| Technicals | QQQ | Price vs 50-day -6.6% vs -5.3%; vs 200-day -1.4% vs -0.3% |
| Risk Resilience | KRYS | Risk Resilience 69 vs 31 |
| Analyst expectations | Not covered | Not covered |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of KRYS and QQQ and are excluded from the count.
AIQ Decision Stability
The conclusion rests on a wide gap and broad agreement. It is unlikely to turn on a single session.
- The AIQ gap is wide at 23 points. (supports the conclusion holding)
- The leader's advantage has been widening. (supports the conclusion holding)
- The leader's signal state is cleanly positive. (supports the conclusion holding)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on KRYS.
How the comparison changed
120 daily snapshots · May 27 – Nov 13KRYS lead: Strengthening — the AIQ differential moved from 10 to 23 points over 30 sessions.
- Today
- KRYS +23
- 69 vs 46
- 7 sessions ago
- KRYS +22
- 72 vs 50
- 30 sessions ago
- KRYS +10
- 73 vs 63
- 90 sessions ago
- KRYS +16
- 72 vs 56
The lead has not changed hands in this window.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
3 bullish / 0 bearish / 1 neutral
Only KRYS
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (3.65%)
- MACD Bullish Crossover — bullish, momentum, short horizon
- MACD Histogram Expanding Bullish — bullish, momentum, short horizon
2 bullish / 1 bearish, conflicted
Only QQQ
- Price Lost 200-Day MA — bearish, trend, long horizon
- Drawdown Recovery Signal — bullish, risk_regime, long horizon (-14.8%)
Both carry 1 more signal that do not separate them: Golden Cross Active.
QQQ is conflicted, so the timing case there is weaker than the score alone suggests.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.15%, AIQ 0 points).
Price and the AIQ Score both moved down over the latest session (price -1.2%, AIQ -1 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1QQQ closes the Value gap — currently 54 points behind, the largest single contributor to KRYS's edge.
- 2QQQ's Price Lost 200-Day MA resolves — a bearish trend rule currently active against it.
- 3KRYS's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict.
- 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
Split| Metric | KRYS | QQQ |
|---|---|---|
| Revenue growth (YoY) | 6.8% | — |
| EPS growth (YoY) | 15.1% | — |
| Gross margin | 93.4% | — |
| Operating margin | 48.4% | — |
| Return on equity (TTM) | 4.4% | — |
| Debt to equity | 0.01 | — |
Performance
KRYS leads 4 of 6 windows| Metric | KRYS | QQQ |
|---|---|---|
| 1 week (5 sessions) | 1.4% | 3.6% |
| 1 month (20 sessions) | -3.6% | -4.2% |
| 3 months (63 sessions) | -9.1% | -6.8% |
| 6 months (126 sessions) | -0.3% | -4.1% |
| Year to date | 23.8% | 10.7% |
| 1 year (252 sessions) | 50.3% | 9.5% |
Technicals
QQQ has the stronger structure| Metric | KRYS | QQQ |
|---|---|---|
| RSI (14) | 43 | 42.8 |
| ADX (14) | 18.5 | 30.3 |
| Price vs 50-day | -6.6% | -5.3% |
| Price vs 200-day | -1.4% | -0.3% |
| Volatility (1M, annualized) | 47.8% | 35.4% |
Risk
KRYS is the more resilient| Metric | KRYS | QQQ |
|---|---|---|
| Beta | 0.74 | 1.46 |
| Sharpe ratio | 1.16 | 0.44 |
| Sortino ratio | 1.67 | 0.62 |
| Max drawdown | -21.8% | -14.8% |
| Current drawdown | -19.3% | -10.5% |
| Annualized volatility | 39.4% | 21.5% |
| Value at risk (95%) | -3.5% | -2% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, KRYS or QQQ?
On the Algovestiq AIQ Score, KRYS is the stronger of the two as of Nov 15, 2026, scoring 69 against QQQ's 46. The edge comes from value and risk resilience. QQQ is not without a case — it holds the better quality profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is KRYS or QQQ the better buy right now?
KRYS carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Stable — 3 of 4 covered evidence groups agree. A Stable rating means the gap is wide and the evidence is broad, so the conclusion is unlikely to turn on a single session.
Why does the AIQ Score favor KRYS over QQQ?
The composite weights Quality, Value, Momentum and Risk Resilience. KRYS leads Value by 54 points; KRYS leads Risk Resilience by 38 points; KRYS leads Momentum by 25 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, KRYS or QQQ?
Analyst price targets imply +40.4% upside for KRYS and not covered for QQQ. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, KRYS or QQQ?
KRYS is the better-valued of the two on the peer-relative Value factor. KRYS on the peer-relative Value factor, by 54 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, KRYS or QQQ?
Growth figures are not covered for both names. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, KRYS or QQQ?
KRYS on the Momentum factor, by 25 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, KRYS or QQQ?
KRYS is the more resilient of the two, so the other name carries the higher downside risk. KRYS on Risk Resilience, by 38 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is KRYS more profitable than QQQ?
Margin data is not comparable for both names in the current snapshot.
Is KRYS's lead over QQQ getting stronger or weaker?
KRYS lead: Strengthening — the AIQ differential moved from 10 to 23 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.
What would change the KRYS vs QQQ verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: QQQ closes the Value gap — currently 54 points behind, the largest single contributor to KRYS's edge; QQQ's Price Lost 200-Day MA resolves — a bearish trend rule currently active against it; KRYS's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
What do the current signals say about KRYS and QQQ?
KRYS: 3 bullish / 0 bearish / 1 neutral. QQQ: 2 bullish / 1 bearish, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on KRYS is Golden Cross Active (bullish, long horizon). On QQQ it is Golden Cross Active (bullish, long horizon).
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.